MedTrace Logo

Predictors of Residual Tumor at Second Transurethral Resection for pT1 Non-muscle Invasive Bladder Cancer

NCT06205277 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1300

Last updated 2024-01-12

No results posted yet for this study

Summary

The START study is a multicentre retrospective project. The aim is to identify clinico-pathological predictors of residual tumor at time of second transurethral resection of bladder tumor (re-TURBt) and to identify well-selected candidates for a risk-adapted strategy in which this procedure could be safely spared.

Conditions

Interventions

PROCEDURE

Second TURBt

Second TURBt for pT1 NMIBC as per current EAU Guidelines.

Sponsors & Collaborators

  • University of Trieste

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-01-01
Primary Completion
2023-12-31
Completion
2023-12-31

Countries

  • Italy

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06205277 on ClinicalTrials.gov